Toronto Dominion Bank
CEROW

Toronto Dominion Bank’s CERo Therapeutics Warrants CEROW Stock Holding History

Toronto Dominion Bank’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-381,018
Closed -$5.33K – 2306
2025
Q3 		$5.33K Sell
381,018
-300
-0.1% -$5 ﹤0.01% 1791
2025
Q2 		$9.07K Buy
+381,318
New +$5.91K ﹤0.01% 1642

Other funds holding CEROW

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Toronto Dominion Bank's CEROW Position: Q4 2025 in Review

Toronto Dominion Bank sold out of CERo Therapeutics Warrants (CEROW) in Q4 2025, closing a stake of 381,018 shares — an estimated $5.33K sold.

Toronto Dominion Bank first reported a position in CEROW in Q2 2025 and held it in 2 quarters. The position peaked at $9.07K in Q2 2025. 1 fund tracked by Wall St. Rank holds CEROW as of Q4 2025.

  • Toronto Dominion Bank reported no remaining CERo Therapeutics Warrants position as of Q4 2025 after selling out during the quarter.
  • Toronto Dominion Bank sold 381,018 CERo Therapeutics Warrants shares in Q4 2025, an estimated $5.33K.
  • Toronto Dominion Bank first reported a position in CERo Therapeutics Warrants in Q2 2025 and held it in 2 quarters.
  • Toronto Dominion Bank's CERo Therapeutics Warrants position peaked at $9.07K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q4 2025.

Based on Toronto Dominion Bank's 13F filing for Q4 2025, filed 17 Feb 2026.